Equity Brief · Healthcare2026-05-20
RMD·Healthcare

ResMed Inc

I · AI-analyse

In het kort

ResMed manufactures devices that help people breathe better during sleep—primarily CPAP machines and other equipment for sleep apnea—and also sells cloud-based software that home health agencies, nursing homes, and medical equipment suppliers use to manage patient records and billing [Yahoo Finance]. They operate in two main segments: Sleep and Breathing Health (the devices) and Residential Care Software (the healthcare management systems).

ResMed is a $30.1 billion medical device company that makes equipment to treat sleep apnea and other breathing disorders, along with software for home healthcare providers [Yahoo Finance]. The company just announced a partnership with Oura, a wearable ring maker, to screen for sleep problems earlier and expand its customer base beyond traditional doctor referrals [Simply Wall St]. Financially, ResMed is exceptionally strong with 27% profit margins, $1.7 billion in free cash flow, and a perfect 10/10 health score [Yahoo Finance].

ResMed is in outstanding financial shape with strong profitability, excellent cash generation, and essentially no net debt.

In het kort AI analysisBetrouwbaarheid 8/10

Sentinellis-score

10/10

Financially healthy

Marktkapitalisatie

$30.1B

Omzet (12 maanden)

$5.1B

II · Recent nieuws

Wat de koers bewoog

3 stories · ranked by relevance

  • macro2026-05-20

    ResMed (RMD) Valuation Check As Oura Sleep Health Collaboration Aims To Expand Sleep Apnea Care Access

    Simply Wall St

  • macro2026-05-19

    Resmed Announces Participation in the 46th Annual William Blair Growth Stock Conference

    Yahoo Finance

  • macro2026-05-19

    Resmed and ŌURA Partner to Expand Access to Sleep Health Education and Care

    Yahoo Finance

Premium · gratis met elk account

The stock has declined nearly 20% over the past three months despite strong fundamentals, indicating investors may be concerned about growth sustainability or competitive pressures not yet visible in the financial data [Simply Wall St].

1 van 4 risico's in dit rapport

Risico's

4

Kansen

4

Waarschuwingssignalen

1

Leiding

10

Nog 18 bevindingen in het volledige rapport — gratis met elk account.

Ontgrendel de volledige analyse van ResMed Inc

Maak een gratis account voor het volledige AI-rapport met bronvermelding in de tekst.

  • 4 risico's, 4 kansen en 1 waarschuwingssignaal — elk met zijn bron
  • Meer dan 100 financiële cijfers met grafieken en vergelijkingen
  • Volledige nieuwssamenvattingen met bronlinks
  • Directie en beloning
  • PDF-export voor offline
Ontgrendel alle 9 bevindingen3 gratis rapporten · geen creditcard

III · Vergelijkbare bedrijven

Misschien ook interessant

Same sector · Healthcare or comparable health

Op je volglijst zetten?

Read three companies free. Geen kaart.

Krijg 3 gratis rapporten
ResMed Inc (RMD) Aandelenanalyse in gewone taal — Sentinellis